Neuren Pharmaceuticals Ltd (ASX:NEU)
Share Price and News
NEUREN PHARMACEUTICALS LIMITED (ASX: NEU) is under the health care sector and is a biopharmaceutical company with a focus on neurological conditions. Developing drugs for neurological disorders is what the company is engaged into and trofinetide (NNZ-2566) and NNZ-2591 are some of its products. Hamilton Pharmaceuticals Inc. and Neuren Pharmaceuticals Inc. are its subsidiaries. The company’s incorporation year was 2001 and is in Burke Rd, Auckland, Australia.